Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated two sequential antibiotic regimens (azithromycin plus ceftriaxone followed by azithromycin; levofloxacin followed by levofloxacin) for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levaquin (levofloxacin) (levofloxacin)
  • Rocephin (Ceftriaxone) (Ceftriaxone)
  • Zithromax (azithromycin) (azithromycin)

Snippet

Sponsor: Pfizer | Conditions: Community-Acquired Pneumonia (CAP) | Phase 4 | Status: COMPLETED